Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.
El Sahly HM, Baden LR, Essink B, Doblecki-Lewis S, Martin JM, Anderson EJ, Campbell TB, Clark J, Jackson LA, Fichtenbaum CJ, Zervos M, Rankin B, Eder F, Feldman G, Kennelly C, Han-Conrad L, Levin M, Neuzil KM, Corey L, Gilbert P, Janes H, Follmann D, Marovich M, Polakowski L, Mascola JR, Ledgerwood JE, Graham BS, August A, Clouting H, Deng W, Han S, Leav B, Manzo D, Pajon R, Schödel F, Tomassini JE, Zhou H, Miller J; COVE Study Group.. Rottenstreich M, et al. BJOG. 2021 Sep 23. doi: 10.1111/1471-0528.16941. Online ahead of print. BJOG. 2021. PMID: 34554630. Freeman-Cook K, et al. Cancer Cell. 2021 Sep 11:S1535-6108(21)00449-9. doi: 10.1016/j.ccell.2021.08.009. Online ahead of print. Cancer Cell. 2021. PMID: 34520734.
![top](data:image/svg+xml,%3Csvg%20xmlns="http://www.w3.org/2000/svg"%20width="16"%20height="16"%3E%3Crect%20fill-opacity="0"/%3E%3C/svg%3E "top")